The benefits of putting an end to the opioid crisis burden exceeded $95 billion in 2016 according to an analysis released by Altarum, underscoring the importance of swift investment in evidence-based interventions.
While health plans encourage wearables, the assessment of the benefits of wearables has been the target of several recent studies. Researches are interested in discovering the “stickiness” of the devices and their effect on wellness program success. The studies note that the Inside employer and payer wellness programs as well as the independent user reflect positively.
A recent study from the University of Kansas School of Pharmacy has uncovered a disturbing prescribing trend in prescribing opioids for nonmalignant chronic pain (defined as pain lasting for more than three months not associated with cancer). The study adds definition to the opioid landscape starting with pain and possibly leading to addiction.
States have broad authority to influence and regulate the prescribing and dispensing of prescription drugs and do so in a variety of ways. CDC provides data and resources to equip and inform states about putting into practice strategies that help prevent high-risk prescribing and improve treatment for battles against opioid addiction and overdose.
The extent of the opioid crisis means years of work, resources, and programming from payers, providers, and patients. A recent effort, funded by the Robert Wood Johnson Foundation, conducted a literature review and interviewed insurers, providers, and patient advocates looking for the most current efforts, data, and experiences from the frontlines of the opioid crisis.
This week and in separate press releases, Anthem and OptumRx announced significant improvements through their opioid programs. These successes mark new options for the battle in, what the President declared, the opioid "national emergency". The following are important points from their separate announcements.
For payers, identifying doctors who write more opioid prescriptions can be key for any successful opioid management program. Using the one factor influencing opioid prescription habits, payers can target education improving the overall provider network performance. Physicians trained at the United States’ lowest-ranked medical schools write more opioid prescriptions than physicians trained at the highest-ranked schools, according to a study by Princeton University.
Behavioral health claims skyrocket for any number and combination of factors. Behavioral health care will increase in cost and utilization with a number of factors driving this, including the:
According to the CDC, drug overdoses are the leading cause of accidental death in the United States. Of the overdose deaths that occurred in 2015, 63 percent involved an opioid. Payer options for managing efforts against opioid overuse range from monitoring population data to working with provider networks.
The National Council for Behavioral Health and the National Council Medical Director Institute released a far-reaching report this month: The Psychiatric Shortage: Causes and Solutions. As a recognized leader in behavioral health reviews, this BHM Healthcare Insider Blog brings selections from the executive summary focusing on the behavioral healthcare shortages and solutions.